Crohn's Disease News and Research

Latest Crohn's Disease News and Research

Discovery sheds light on an important aspect of gut health and mucosal immunity

Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

7 Sep 2022

Researchers identify multiple genes and rare variants linked with Crohn's disease susceptibility

An international consortium of researchers has identified genetic variants in 10 genes that elevate a person's susceptibility to Crohn's disease, a form of inflammatory bowel disease.

29 Aug 2022

Oral chlorophyllin supplement alleviates inflammatory bowel disease

The dietary supplement chlorophyllin alleviates inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, according to researchers from the Center for Diabetes and Metabolism Research at Sichuan University in China and from Cedars Sinai Medical Center in Los Angeles.

17 Aug 2022

Researchers identify mechanistic principles for engineering antibodies to enhance cadherin adhesion

Future treatments for advanced cancer could work by sticking cancer cells in place and preventing their spread around the body. A new study by researchers at the University of California, Davis, and the University of Washington shows how an antibody strengthens bonds between cells. The work is published Aug. 3 in Proceedings of the National Academy of Sciences.

5 Aug 2022

Pregnant women with IBD and their babies face increased risks and complications

Pregnant women with inflammatory bowel disease (IBD) and their babies face increased risks and complications compared to pregnant women without IBD.

3 Aug 2022

Nutritive intervention could be an effective treatment method in maintaining human health

In a new study, researchers assessed the impact of dietary regulation on human health and disease.

1 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

New treatment guidelines published for anorectal abscess, anal fistula, and rectovaginal fistula

The American Society of Colon and Rectal Surgeons has issued updated guidelines for physicians, published in Diseases of the Colon & Rectum, about how to treat problems of the anus and rectum called anorectal abscess, anal fistula, and rectovaginal fistula.

22 Jul 2022

Study identifies a protein that plays key role in protecting the gastrointestinal tract from inflammation

A protein called Zbtb46, expressed by specialized immune cells, has a major role in protecting the gastrointestinal tract from excessive inflammation, according to a study from researchers at Weill Cornell Medicine.

13 Jul 2022

Newly identified gut bacterial strains could pave the way for IBD and colon cancer prevention

Researchers have isolated five strains of gut bacteria that could pave the way for new inflammatory bowel disease treatments and potentially help prevent some forms of bowel cancer.

5 Jul 2022

New machine learning method may improve the identification of genes that cause diseases

A new machine learning method to model gene expression levels might improve the identification of genes that cause human diseases, according to a new study by Penn State College of Medicine researchers.

28 Jun 2022

Lawmaker takes on insurance companies and gets personal about his health

Scott Wiener made a startling revelation at a spring legislative committee hearing: "I was in the hospital. I experienced the most intense abdominal pain that I could even imagine."

9 Jun 2022

People with inflammatory immune conditions had increased risk of COVID-19-related death before vaccination

People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have been more at risk of dying or needing hospital care if they got COVID-19 before vaccination compared with the general population, according to a new study published in The Lancet Rheumatology.

9 Jun 2022

Betting on ‘golden age’ of colonoscopies, private equity invests in gastro docs

Mariel needed a new gastroenterologist. Having just moved back to San Antonio, the 30-something searched for a doctor to manage her Crohn's disease, an inflammatory bowel condition that is successfully managed with medications and lifelong monitoring — including regular colonoscopies.

27 May 2022

Gut microbiota linked to immunocompromised people's variable response to SARS-CoV-2 vaccination

In a recent study posted to the Research Square* preprint server, researchers assessed whether disturbances in the gut microbiota weaken the serological response to the coronavirus disease 2019 (COVID-19) vaccine in inflammatory bowel disease (IBD) patients.

25 May 2022

Older adults taking antibiotics more likely to develop inflammatory bowel disease

The more antibiotics prescribed to patients 60 and older, the more likely they were to develop inflammatory bowel disease, suggesting antibiotic use could explain some of the growth in Crohn's disease and ulcerative colitis in older people, according to a review of 2.3 million patient records in a study selected for presentation at Digestive Disease Week 2022.

24 May 2022

Crohn's Disease News and Research

Latest Crohn's Disease News and Research

Discovery sheds light on an important aspect of gut health and mucosal immunity

Researchers identify multiple genes and rare variants linked with Crohn's disease susceptibility

Oral chlorophyllin supplement alleviates inflammatory bowel disease

Researchers identify mechanistic principles for engineering antibodies to enhance cadherin adhesion

Pregnant women with IBD and their babies face increased risks and complications

Nutritive intervention could be an effective treatment method in maintaining human health

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

New treatment guidelines published for anorectal abscess, anal fistula, and rectovaginal fistula

Study identifies a protein that plays key role in protecting the gastrointestinal tract from inflammation

Newly identified gut bacterial strains could pave the way for IBD and colon cancer prevention

New machine learning method may improve the identification of genes that cause diseases

Lawmaker takes on insurance companies and gets personal about his health

People with inflammatory immune conditions had increased risk of COVID-19-related death before vaccination

Betting on ‘golden age’ of colonoscopies, private equity invests in gastro docs

Gut microbiota linked to immunocompromised people's variable response to SARS-CoV-2 vaccination

Older adults taking antibiotics more likely to develop inflammatory bowel disease

Serological biomarker predicts severe Crohn's disease seven years prior to diagnosis

Synthetic biologists interrogate single-celled survivalists to understand stress response

Children who grow up with dogs may have protection from Crohn's disease later in life

Antibiotic use could explain the growth in inflammatory bowel disease in older people

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Crohn's Disease News and Research

Latest Crohn's Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in